The Advisory Board updated a great post on their website last month called, “Cancer screenings plummeted last year. Now the ‘missed’ cancers are showing up—and they’re serious.“
Norman Sharpless of the National Cancer Institute says these “missed” cancers could result in “10,000 excess deaths just from breast and colorectal cancers over the next ten years.” Fortunately, the Advisory Board has some straightforward recommendations for corrective action that providers can take to help.
In a nutshell, here are the high points of the article:
- A lot less cancer screenings happened during COVID, for various reasons, and are still not back up to where they should be.
- Yet cancer occurrence rates did not dip, of course.
- Now when cancer screenings are positive, the cancers are more advanced, so providers need to be prepared with the best, most appropriate treatment possible.
- Therefore, providers must “overcorrect” screening rates right now, through outreach and promotion, to catch up.
Estimated Decrease of Cancer Screenings in 2020
“Missed Cancers” – We Can Help
Our excellent health risk assessments for colon, breast, lung and prostate cancer motivate appropriate users to schedule screenings, based on algorithms from widely-accepted research studies. Of course, they are easy to promote through your traditional channels, and really resonate with social media users. Few things you can do will be this effective at increasing screening rates. That’s exactly what these were built to do, in a personalized manner– not generic messaging. We’ll help you get the right patients in the door.
Contact us today to start correcting for these “missed” cancers.
